Who Paid My Doc
Ramin Razavi
Dentist, Prosthodontics McLean, VA Doctor of Dentistry
NPI 1992921761 CMS profile 590753
6829 Elm St, Suite 320, McLean, VA 22101
General payments
$65
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ramin Razavi of McLean, VA is reported in the CMS Open Payments database as having received $65 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 16th percentile of Dentist, Prosthodontics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $23 | 1 | |
| 2019 | General | $42 | 1 |
Beside peers
- Ramin Razavi
- Dentist, Prosthodontics median
- Middle half of Dentist, Prosthodontics
- National median
In program year 2025, general payments to Ramin Razavi were reported at $23. Among 1,396 Dentist, Prosthodontics profiles paid that year, the median was $118 and the middle half received between $44 and $351.
Show as a table
| Year | Ramin Razavi | Dentist, Prosthodontics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $42 | $107 | $36–$389 | $163 |
| 2020 | $0 | $100 | $41–$311 | $114 |
| 2021 | $0 | $129 | $40–$398 | $132 |
| 2022 | $0 | $129 | $47–$460 | $149 |
| 2023 | $0 | $135 | $44–$432 | $160 |
| 2024 | $0 | $142 | $45–$420 | $164 |
| 2025 | $23 | $118 | $44–$351 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
285
Drug cost
$4,089
Branded share of claims
64.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Pentoxifylline | Generic | 54 | $1,186 | |
| Prevident Fluoride (Sodium) | Brand | 39 | $1,045 | |
| Dentagel Fluoride (Sodium) | Brand | 63 | $467 | |
| Sodium Fluoride Fluoride (Sodium) | Brand | 35 | $420 | |
| Prevident 5000 Sensitive Sodium Fluoride/Potassium Nit | Brand | 17 | $302 | |
| Sf 5000 Plus Fluoride (Sodium) | Brand | 17 | $250 | |
| Amoxicillin | Generic | 48 | $227 | |
| Denta 5000 Plus Fluoride (Sodium) | Brand | 12 | $193 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Prosthodontics in Virginia
Bryan Limmer
Dentist, Prosthodontics · Richmond, VA
Mariano Polack
Dentist, Prosthodontics · Gainesville, VA
Sompop Bencharit
Dentist, Prosthodontics · Richmond, VA
Si-Woon Park
Dentist, Prosthodontics · Vienna, VA
Esam Abou Nahlah
Dentist, Prosthodontics · Arlington, VA
Marjan Salari
Dentist, Prosthodontics · Annandale, VA
Related records
Dentist, Prosthodontics in Virginia
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Prosthodontics
Everyone recorded under this specialty, nationwide.
Doctors in Virginia
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.